Corcept Therapeutics
United States
246 articles about Corcept Therapeutics
-
Corcept Therapeutics Inc. Announces $9 Million Private Equity Financing
4/2/2007
-
The Day In Review: InterMune, Inc. Retrenches
3/20/2007
-
Corcept Therapeutics Inc. Announces Phase 3 Study Evaluating CORLUX(R) for Psychotic Major Depression Misses Primary Endpoint
3/20/2007
-
Corcept Therapeutics Inc. Regains Compliance With NASDAQ Minimum Bid Price Rule
1/16/2007
-
Corcept Therapeutics Inc. Receives Nasdaq Delisting Notification
11/20/2006
-
Corcept Therapeutics Inc. Announces $3 Million Private Equity Financing
11/14/2006
-
Corcept Therapeutics Inc. Completes Enrollment In Third Phase 3 Study For Treating Psychotic Major Depression
11/13/2006
-
Corcept Therapeutics Inc. Announces Third Quarter 2006 Results
11/9/2006
-
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
9/29/2006
-
Corcept Therapeutics Inc. Announces Negative Results From The Second Of Three Phase 3 Studies Evaluating CORLUX(R) For Treating The Psychotic Features Of Psychotic Major Depression; Drug Fails 2nd Late-Stage Trial
9/29/2006
-
The Week In Review: A Late Summer Bounce For Biotech
9/5/2006
-
Corcept Therapeutics Inc. Announces Negative Results From The First Of Three Phase 3 Studies Evaluating CORLUX(R) For Treating The Psychotic Features Of Psychotic Major Depression; Stock Tumbles
8/25/2006
-
Corcept Therapeutics Inc. Announces Second Quarter 2006 Results
8/11/2006
-
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
8/7/2006
-
Corcept Therapeutics Inc. Announces Publication Of Phase 2 Clinical Study Results In The Journal Of Biological Psychiatry
8/7/2006
-
Corcept Therapeutics Inc. To Present At C.E. Unterberg, Towbin Emerging Growth Conference On July 11, 200
7/10/2006
-
Corcept Therapeutics Inc. Completes Enrollment In Second Phase 3 Study For Treating Psychotic Major Depression
5/22/2006
-
Corcept Therapeutics Inc. Announces First Quarter 2006 Results
5/10/2006
-
Corcept Therapeutics Inc. Completes Enrollment In Phase 3 Study For Treating Psychotic Major Depression
5/2/2006
-
Corcept Therapeutics Inc. Announces Fourth Quarter 2005 Results
3/9/2006